Global X MANAGEMENT CO LLC Boosts Stake in HealthEquity, Inc. (HQY)
Global X MANAGEMENT CO LLC lifted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 59.7% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 13,045 shares of the company’s stock after buying an additional 4,878 shares during the period. Global X MANAGEMENT CO LLC’s holdings in HealthEquity were worth $660,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in shares of HealthEquity by 3.0% during the second quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after buying an additional 122,061 shares during the period. First Trust Advisors LP lifted its stake in shares of HealthEquity by 17.0% during the second quarter. First Trust Advisors LP now owns 94,283 shares of the company’s stock worth $4,698,000 after buying an additional 13,676 shares during the period. Dimensional Fund Advisors LP lifted its stake in shares of HealthEquity by 25.3% during the second quarter. Dimensional Fund Advisors LP now owns 473,433 shares of the company’s stock worth $23,591,000 after buying an additional 95,514 shares during the period. Fred Alger Management Inc. lifted its stake in shares of HealthEquity by 30.4% during the second quarter. Fred Alger Management Inc. now owns 265,369 shares of the company’s stock worth $13,223,000 after buying an additional 61,880 shares during the period. Finally, Russell Investments Group Ltd. acquired a new stake in shares of HealthEquity during the second quarter worth $1,362,000. Institutional investors and hedge funds own 91.75% of the company’s stock.
WARNING: This news story was originally published by Watch List News and is owned by of Watch List News. If you are viewing this news story on another publication, it was illegally copied and republished in violation of U.S. & international copyright and trademark law. The original version of this news story can be read at https://www.watchlistnews.com/global-x-management-co-llc-boosts-stake-in-healthequity-inc-hqy/1711782.html.
HealthEquity, Inc. (NASDAQ HQY) opened at $50.17 on Friday. The stock has a market cap of $3,070.00, a price-to-earnings ratio of 79.00, a P/E/G ratio of 2.18 and a beta of 1.77. HealthEquity, Inc. has a 1 year low of $37.62 and a 1 year high of $55.31.
HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 5th. The company reported $0.27 earnings per share for the quarter, beating analysts’ consensus estimates of $0.14 by $0.13. HealthEquity had a net margin of 20.27% and a return on equity of 13.93%. The company had revenue of $56.90 million during the quarter, compared to analysts’ expectations of $55.66 million. During the same quarter in the previous year, the company earned $0.16 earnings per share. The firm’s revenue for the quarter was up 28.7% on a year-over-year basis. research analysts forecast that HealthEquity, Inc. will post 0.7 EPS for the current fiscal year.
In other HealthEquity news, VP Jon Soldan sold 25,000 shares of HealthEquity stock in a transaction on Monday, August 28th. The shares were sold at an average price of $40.68, for a total value of $1,017,000.00. Following the completion of the transaction, the vice president now owns 30,652 shares of the company’s stock, valued at $1,246,923.36. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Ashley Dreier sold 10,000 shares of HealthEquity stock in a transaction on Wednesday, September 6th. The shares were sold at an average price of $45.50, for a total transaction of $455,000.00. Following the completion of the transaction, the vice president now directly owns 15,652 shares of the company’s stock, valued at approximately $712,166. The disclosure for this sale can be found here. Insiders sold 1,587,770 shares of company stock valued at $82,754,799 in the last ninety days. 29.00% of the stock is owned by corporate insiders.
HQY has been the subject of a number of research reports. Zacks Investment Research upgraded shares of HealthEquity from a “hold” rating to a “buy” rating and set a $58.00 target price for the company in a research report on Wednesday, October 11th. BidaskClub upgraded shares of HealthEquity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. TheStreet upgraded shares of HealthEquity from a “c” rating to a “b” rating in a research report on Monday, July 31st. Cantor Fitzgerald restated a “buy” rating and set a $56.00 target price on shares of HealthEquity in a research report on Tuesday, August 29th. Finally, Robert W. Baird restated a “hold” rating on shares of HealthEquity in a research report on Thursday, September 21st. Three investment analysts have rated the stock with a hold rating and eight have assigned a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus target price of $57.50.
HealthEquity Company Profile
HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.
Receive News & Ratings for HealthEquity Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.